Mediar Therapeutics Funding: $181M Raised, Series A (2023)

Mediar Therapeutics is based in Boston. It has raised $181M in total funding. Latest round: Series A. Backed by Amplitude Ventures, ICG, Longwood Fund.

Mediar Therapeutics funding overview

Mediar Therapeutics is based in Boston. Mediar Therapeutics has raised $181M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Mediar Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Amplitude Ventures, ICG, Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, Novartis Venture Fund and 9 others. 15 distinct backers are named across the disclosed rounds.

Mediar Therapeutics at a glance

Total raised
$181M
Latest round
Series A
Latest round date
March 2023
Headquarters
Boston
Notable investors
Amplitude Ventures, ICG, Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, Novartis Venture Fund, Sofinnova Partners, Pfizer Ventures

Frequently asked about Mediar Therapeutics funding

How much has Mediar Therapeutics raised?
Mediar Therapeutics has raised $181M in total disclosed funding across the rounds on record.
Who has invested in Mediar Therapeutics?
Amplitude Ventures, ICG, Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, Novartis Venture Fund are named among the investors backing Mediar Therapeutics.
What was the latest Mediar Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is Mediar Therapeutics based?
Mediar Therapeutics is based in Boston.
When did Mediar Therapeutics last raise?
The last disclosed Mediar Therapeutics round closed in March 2023 at Series A.

We update the Mediar Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.

Companies related to Mediar Therapeutics (26)

Browse related funding lists (9)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades